BUZZ-Personalis rises as Medicare extends coverage to lung cancer test

Reuters
02/10
BUZZ-<a href="https://laohu8.com/S/PSNL">Personalis</a> rises as Medicare extends coverage to lung cancer test

** Shares of U.S.-based cancer diagnostics firm Personalis PSNL.O rise 2.3% to $8.01 premarket

**  Co says Medicare will now cover its NeXT Personal test for monitoring early-stage non-small cell lung cancer, the most common form of the disease

** Says the test tracks tiny bits of circulating tumor DNA (ctDNA) in blood that can indicate the presence of cancer; analyzes hundreds of tumor-specific mutations to guide ongoing care decisions

** Move follows Medicare approval for the same test in breast cancer patients, co says

** Medicare is the U.S. government health insurance program for people aged 65 and older

** Shares rose ~38% in 2025

(Reporting by Sahil Pandey in Bengaluru)

((Sahil.Pandey@thomsonreuters.com))

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10